Volume 13, number 2
 PDF Downloads: 1488

Topical and Oral Cyclosporine for A Case of Severe Limbal Vernal Keratoconjunctivitis with Complete Corneal Involvement.

Norah Fahad Al Kheraiji1 and Hamad Al-Fraikh2  

1 Department of Ophthalmology, King Saud University, Riyadh, Saudi Arabia.

2 Anterior Segment and Uveitis Divisions, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.

Corresponding Author Email: kheraiji@yahoo.com

DOI : http://dx.doi.org/10.13005/bbra/2088

ABSTRACT: This case report describes the clinical course and management of a patient with severe limbal vernal keratoconjunctivitis, with corneal involvement. The patient had a significant risk of visual loss at presentation. The disease was recalcitrant to conventional treatment. Topical and oral cyclosporine was introduced, resulting in a significant decrease in inflammation. In cases of severe ocular allergic keratoconjunctivitis that is vision threatening and refractory to conventional therapy, oral cyclosporine is a helpful option to to preserve vision and the eye.

KEYWORDS: cyclosporine; vernal keratoconjunctivitis; refractory

Download this article as: 
Copy the following to cite this article:

Al Kheraiji N. F, Al-Fraikh H. Topical and Oral Cyclosporine for A Case of Severe Limbal Vernal Keratoconjunctivitis with Complete Corneal Involvement. Biosci Biotech Res Asia 2016;13(2).
Copy the following to cite this URL:

Al Kheraiji N. F, Al-Fraikh H. Topical and Oral Cyclosporine for A Case of Severe Limbal Vernal Keratoconjunctivitis with Complete Corneal Involvement. Biosci Biotech Res Asia 2016;13(2). Available from: https://www.biotech-asia.org/?p=11271

[ HTML Full Text]

Back to TOC